Related Experiment Video
Updated: Jul 30, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change
Joy E Lawn1, Eric O Ohuma1, Ellen Bradley1
1Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK.
Insights
Small vulnerable newborns (SVNs) include preterm non-SGA, term SGA, and preterm SGA. Over half of neonatal deaths and many stillbirths are linked to these SVN types, highlighting the need for better data and targeted interventions.
Area of Science:
- Neonatal Health
- Global Public Health
- Perinatal Epidemiology
Background:
- Small newborns face significant mortality risks and lifelong human capital loss.
- Existing measures for newborn vulnerability, like low-birthweight (LBW), are insufficient as LBW reduction targets remain unmet.
- Low-birthweight arises from preterm birth or fetal growth restriction (FGR), leading to small for gestational age (SGA) infants.
Purpose of the Study:
- To estimate the global prevalence of three mutually exclusive types of small vulnerable newborns (SVNs): preterm non-SGA, term SGA, and preterm SGA.
- To assess the contribution of these SVN types to neonatal mortality and stillbirths.
- To advocate for improved data collection and classification of newborns for targeted interventions.
Main Methods:
- Utilized individual-level data from 23 national datasets (approx. 110 million livebirths) and 31 studies (approx. 0.4 million livebirths) between 2010-20.
- Estimated the prevalence of preterm non-SGA, term SGA, and preterm SGA livebirths for the year 2020.
- Analyzed national data on stillbirths (≥22 weeks gestation) to determine the proportion of preterm and term stillbirths that were SGA.
Main Results:
- In 2020, global estimates indicated 11.9 million preterm non-SGA births, 21.9 million term SGA births, and 1.5 million preterm SGA births.
- Small vulnerable newborns accounted for over half (55.3%) of the 2.4 million global neonatal deaths in 2020.
- Approximately 74% of stillbirths were preterm, with 16.0% being preterm SGA, and about one-fifth of term stillbirths were SGA.
Conclusions:
- The classification of small newborns into specific vulnerability types (preterm non-SGA, term SGA, preterm SGA) is crucial for understanding their impact on mortality.
- Integrating stillbirths into burden assessments and relevant indicators is essential, given an estimated 1.9 million stillbirths annually share similar vulnerability pathways.
- Improving data by systematically recording weight, gestational age, and classification for all newborns, liveborn or stillborn, can accelerate prevention and target care for the most vulnerable infants.
Abstract:
Small newborns are vulnerable to mortality and lifelong loss of human capital. Measures of vulnerability previously focused on liveborn low-birthweight (LBW) babies, yet LBW reduction targets are off-track. There are two pathways to LBW, preterm birth and fetal growth restriction (FGR), with the FGR pathway resulting in the baby being small for gestational age (SGA). Data on LBW babies are available from 158 (81%) of 194 WHO member states and the occupied Palestinian territory, including east Jerusalem, with 113 (58%) having national administrative data, whereas data on preterm births are available from 103 (53%) of 195 countries and areas, with only 64 (33%) providing national administrative data. National administrative data on SGA are available for only eight countries. Global estimates for 2020 suggest 13·4 million livebirths were preterm, with rates over the past decade remaining static, and 23·4 million were SGA. In this Series paper, we estimated prevalence in 2020 for three mutually exclusive types of small vulnerable newborns (SVNs; preterm non-SGA, term SGA, and preterm SGA) using individual-level data (2010-20) from 23 national datasets (∼110 million livebirths) and 31 studies in 18 countries (∼0·4 million livebirths). We found 11·9 million (50% credible interval [Crl] 9·1-12·2 million; 8·8%, 50% Crl 6·8-9·0%) of global livebirths were preterm non-SGA, 21·9 million (50% Crl 20·1-25·5 million; 16·3%, 14·9-18·9%) were term SGA, and 1·5 million (50% Crl 1·2-4·2 million; 1·1%, 50% Crl 0·9-3·1%) were preterm SGA. Over half (55·3%) of the 2·4 million neonatal deaths worldwide in 2020 were attributed to one of the SVN types, of which 73·4% were preterm and the remainder were term SGA. Analyses from 12 of the 23 countries with national data (0·6 million stillbirths at ≥22 weeks gestation) showed around 74% of stillbirths were preterm, including 16·0% preterm SGA and approximately one-fifth of term stillbirths were SGA. There are an estimated 1·9 million stillbirths per year associated with similar vulnerability pathways; hence integrating stillbirths to burden assessments and relevant indicators is crucial. Data can be improved by counting, weighing, and assessing the gestational age of every newborn, whether liveborn or stillborn, and classifying small newborns by the three vulnerability types. The use of these more specific types could accelerate prevention and help target care for the most vulnerable babies.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Teratogenicity
Mitral Valve Prolapse III: Nursing Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

